News
Northeastern researcher elected president of the Complex Systems Society
The science of complex systems was born in the mid-20th century, but it has only recently begun to mature into a research field with real-world relevance.
December 04, 2012
Lasers reveal the hidden lives of biomolecules
All around and inside us, an elaborate dance of molecular vibrations is constantly taking place.
December 03, 2012
The rungs of mathematical discovery
More than a decade ago, mathematics professor Valerio Toledano Laredo was puzzling over the relationship between the symmetries of macroscopic and microscopic systems when he discovered a brand new set of differential equations.
November 29, 2012
The real NCIS
The forensics lab isn’t nearly as glamorous as television would have you think. Jacquelyn Horman would know. The chemistry major had watched her fair share of the police procedural dramas NCIS and CSI: Miami before landing a co-op job with the crime lab at the Mesa, Ariz., police department. The lab work — not glitzy but critical to investigations — strengthened her interest in the field, she said.
November 26, 2012
Chemistry student group earns chemical society’s high honor
Northeastern University’s student chapter of the American Chemical Society has been designated as “outstanding,” the highest honor bestowed upon a university by the world’s largest scientific society.
November 13, 2012
Using Salamanders to Study Regeneration
Dr. James Monaghan, an assistant professor of regeneration biology at Northeastern University, has been studying the Mexican axolotl salamander’s amazing regenerative properties to discover the cellular and genetic basis of tissue regeneration — findings that could have a huge impact on regenerative medicine.
November 09, 2012
New Chemistry Professor Researching Better Ways To Treat Cancer
It has been a whirlwind 10 months for new Northeastern University professor Carla Mattos. She moved to Boston, set up a new lab in structural biology, and won a highly competitive grant for a piece of new equipment that will expand research opportunities for the entire Northeastern community.
November 07, 2012
Psychology Professor Talks Science of Compassion at PopTech
When someone is victimized, do you see yourself in them in some manner? It could be why you feel compassion toward them.
October 22, 2012
Global Health Initiative to address neglected tropical diseases
Ninety percent of global healthcare and medical research money is spent on diseases that affect only 10 percent of the population, according to Michael Pollastri, a professor of chemistry and chemical biology who spoke at the College of Science Colloquium last Friday.
October 16, 2012
Release: Fluoxetine Increases Aggressive Behavior, Affects Brain Development Among Adolescent Hamsters
Fluoxetine was the first drug approved by the FDA for major depressive disorder (MDD) in children and adolescents, and to this date, it remains one of only two selective serotonin reuptake inhibitors (SSRIs) registered for treatment of MDD in children and adolescents, despite reports that indicate this class of drugs is associated with side effects, such as agitation, hostility and aggression.
October 01, 2012
Scientists study seawalls on the seashore
Oyster reefs and sandy beaches have historically bordered many picturesque coastlines. But in an effort to prevent erosion, coastal developers are increasingly replacing these living shorelines with rocks and seawalls.
September 25, 2012
The building blocks of dyslexia
While dyslexia is most often classified as a reading disorder, it is also well known to affect how individuals process spoken language.
September 20, 2012
3Qs: New clues to unlocking the genome
Last week, Nature Magazine, Genome Research and Genome Biology published 30 papers on breakthrough research that will change the face of genetics.
September 18, 2012
Northeastern’s Barnett Institute Announces Formation of Leading Analytics Company, BioAnalytix, LLC
Biologic drugs represent one of the most important and fastest growing areas in healthcare today, and especially as these biopharmaceuticals begin to come off patent and developers prepare for biosimilars to hit the market, there is a growing need for advanced analytics throughout the drug development process.
September 17, 2012